₹-2.75
(Market cap
₹501 Cr
Recently Viewed
Clear AllMarket cap
₹501 Cr
Revenue (TTM)
₹71 Cr
P/E Ratio
25.3
P/B Ratio
4.2
Div. Yield
0.2 %
Value Research Rating
Quality Score
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹20 Cr
ROE
18.7 %
ROCE
25.2 %
Industry P/E
33.84
EV/EBITDA
15
Debt to Equity
0
Book Value
₹100.2
EPS
₹16.5
Face value
10
Shares outstanding
12,003,000
CFO
₹62.75 Cr
EBITDA
₹98.48 Cr
Net Profit
₹78.95 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Prevest Denpro
| -15.1 | 4.2 | -7.9 | -18.2 | 6.9 | -- | -- |
|
BSE Healthcare
| -2.1 | -2.7 | -2.2 | 5.2 | 22.9 | 13.5 | 10.7 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
Prevest Denpro
| -18.1 | 41.9 | 16.0 | -16.9 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Prevest Denpro
|
417.3 | 500.8 | 71.3 | 19.8 | 31.4 | 17.9 | 25.3 | 4.2 |
| 832.0 | 1,504.8 | 77.0 | 16.4 | -- | 43.4 | 95.3 | 14.0 | |
| 232.2 | 442.1 | 135.7 | 16.1 | -- | 36.8 | 27.4 | 6.9 | |
| 1,724.3 | 28,366.1 | 6,112.8 | 847.2 | 17.2 | 9.2 | 33.5 | 2.9 | |
| 296.4 | 386.4 | 106.6 | 8.0 | -- | 12.7 | 48.1 | 3.4 | |
| 190.4 | 1,049.0 | 264.6 | 19.3 | 8.9 | 6.2 | 45.3 | 4.6 | |
| 868.7 | 10,425.6 | 6,537.7 | 207.0 | 4.6 | 11.5 | 50.4 | 5.5 | |
| 1,453.1 | 14,721.0 | 1,781.6 | 341.3 | 19.8 | 12.4 | 42.3 | 4.9 | |
| 201.1 | 1,070.0 | 414.3 | 20.3 | 8.0 | 3.4 | 52.6 | 1.7 | |
| 375.1 | 485.5 | 18.6 | 25.3 | -9.9 | -10.2 | -- | 0.6 |
No Review & Analysis are available.
Medical Equipment
Incorporated
1999
Chairman
Atul Modi
Managing Director
Atul Modi
Headquarters
Samba, Union Territory
Website
Looking for more details about Prevest Denpro Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
The share price of Prevest Denpro Ltd is ₹417.25 (BSE) as of 13-Apr-2026 IST. Prevest Denpro Ltd has given a return of 6.92% in the last 3 years.
The P/E ratio of Prevest Denpro Ltd is 25.28 times as on 13-Apr-2026, a 25 discount to its peers’ median range of 33.84 times.
The P/B ratio of Prevest Denpro Ltd is 4.17 times as on 13-Apr-2026, a 43 premium to its peers’ median range of 2.92 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
28.34
|
4.87
|
|
2024
|
26.26
|
4.78
|
|
2023
|
21.25
|
4.59
|
|
2022
|
37.45
|
7.59
|
|
2021
|
0.00
|
0.00
|
The 52-week high and low of Prevest Denpro Ltd are Rs 622.05 and Rs 318.15 as of 13-Apr-2026.
Prevest Denpro Ltd has a market capitalisation of ₹ 501 Cr as on 13-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Prevest Denpro Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.